SEC Form 4 · accession 0001437749-17-014638
PLx Pharma Inc. · PLXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Valentino
Officer — Executive Chairman · Director
Period of report
Aug 10, 2017
Accepted (ET)
Aug 14, 2017 · 11:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497504
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2017 | A | 30,000 | $0.00 | A | 152,386 | D |
Table II — derivative securities
No Table II lines on this filing.